Cuizon, Edraline .

HRN: 14-84-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFUROXIME 750MG (VIAL)
12/19/2023
12/21/2023
IV
1.5g
Q8 X 6 Doses
S/P Repeat LTCS
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: